hCD3EDG/hCD19/hCD28
Nomenclature
C57BL/6JSmo-Cd28tm2(hCD28)Cd3etm1(hCD3E)Cd3dtm1(hCD3D)Cd3gtm1(hCD3G)Cd19tm1(hCD19)Smoc
Cat. NO.
NM-XA-240981
Strain State
Repository Live
Model Description
Validation Data

Fig.1 CD3 specific expression analysis in WT C57BL/6 and HO/HO/HO hCD3EDG/hCD28/hCD19 mice in peripheral blood, lymph node and spleen.

Fig.2 CD19 specific expression analysis in WT C57BL/6 and HO/HO/HO hCD3EDG/hCD28/hCD19 mice in peripheral blood, lymph node and spleen.

Fig.3 CD28 specific expression analysis in WT C57BL/6 and HO/HO/HO hCD3EDG/hCD28/hCD19 mice in peripheral blood, lymph node and spleen.

Fig.4 Frequency of leukocyte subpopulations in WT C57BL/6 and HO/HO/HO hCD3EDG/hCD28/hCD19 mice by flow cytometry.

Fig.5 Frequency of leukocyte subpopulations in WT C57BL/6 and HO/HO/HO hCD3EDG/hCD28/hCD19 mice in (A) lymph node, (B) peripheral blood(PB) and (C) spleen by flow cytometry(female, 5-6-week-old, n=3).

Fig.6 Organ index of WT C57BL/6 and HO/HO/HO hCD3EDG/hCD28/hCD19 mice (female, 5-6-week-old, n=3).

Table 1. Blood routine examination of hCD3EDG/hCD19/hCD28 knockin mice. Values are expressed as Mean±SEM.
Abbr. HO, homozygous; WT, wild type.

Table 2. Biochemical test of serum from hCD3EDG/hCD19/hCD28 knockin mice. Values are shown as Mean±SEM.
Abbr. HO, homozygous; WT, wild type.

Fig.7 Detection immunoglobulin levels in serum by ELISA.
Serum was collected from wild-type C57BL/6 mice (WT) and homozygous hCD3EDG/hCD19/hCD28 mice (HO/HO/HO) (n=8 in each group, 7-8 weeks old, Mean±SEM).

Fig.8 Detection C3c and C4 levels in serum by ELISA.
Serum was collected from wild-type C57BL/6 mice (WT) and homozygous hCD3EDG/hCD19/hCD28 mice (HO/HO/HO) (n=3-8 for C3c detection and n=8 for C4 detection, 7-8 weeks old, Mean±SEM).
You may also like
Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreWorkshop:Progress and Advances in Preclinical immuno-Oncology Research
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
Learn moreCustomizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!
At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more